Protein-Protein Interactions Characterization Service | HDX-MS

What Is Protein-Protein Interactions Characterization?

Protein-protein interactions characterization investigates the structural features and conformational changes associated with protein complex formation. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) measures the exchange of protein backbone amide hydrogens with deuterium in solution. Exchange behavior is influenced by local hydrogen bonding and conformational fluctuations, providing peptide-level information about protein structural protection and dynamics.

 

By comparing deuterium uptake between free and bound protein states, HDX-MS identifies regions showing altered protection upon complex formation. Reduced exchange may indicate structural stabilization, while increased exchange can reflect greater local flexibility or exposure. These differences help identify potential interaction regions and binding-induced conformational changes. Because both direct contact and distal structural responses can influence exchange, the results are interpreted alongside available binding evidence and structural information.

 

Protein-Protein Interactions Characterization Service at MtoZ Biolabs

MtoZ Biolabs provides HDX-MS-based protein-protein interactions characterization for purified protein systems with established or supported binding relationships. Our service combines comparative deuterium exchange measurements, high-resolution Q-TOF mass spectrometry, and peptide-level data analysis to investigate the structural consequences of protein binding.

Our service focuses on three analytical areas:

1. Binding-Associated Region Mapping

Identify peptide regions exhibiting differential deuterium uptake upon complex formation and prioritize candidate interaction regions for further investigation.

2. Conformational Dynamics Analysis

Characterize changes in local structural protection and flexibility between free and bound protein states across multiple labeling time points.

3. Structure-Guided Interpretation

Integrate differential HDX profiles with available protein structures or predicted models to visualize the spatial distribution of binding-associated changes.

Experimental conditions and comparison strategies are selected according to the protein system, available interaction evidence, and research objectives.

When HDX-MS-Based Protein-Protein Interactions Characterization Is a Good Fit

HDX-MS is particularly valuable when protein interaction experiments have established an association, but additional structural evidence is needed to explain the interaction. The following experimental situations are well suited to this approach:

1. Confirmed Binding with an Unresolved Interface

Binding assays such as SPR or BLI have established an interaction, but the protein regions potentially involved in complex formation remain unclear.

2. Unexplained Binding-Dependent Structural Changes

Biochemical or functional experiments suggest that protein association alters molecular behavior, but the accompanying conformational changes have not been characterized.

3. Limited Structural Information

High-resolution structural data are unavailable or difficult to obtain, while purified proteins remain suitable for comparative solution-state analysis.

4. Comparative Analysis of Protein States

Researchers need to investigate whether mutations or changes in experimental conditions alter the structural response to protein binding.

HDX-MS is most suitable when purified proteins remain stable and sufficient complex occupancy can be maintained during deuterium labeling.

Analysis Workflow

1. Experimental Design and Sample Evaluation

Review protein sequences, purity, binding evidence, and buffer composition. Define free and bound protein states, comparison groups, labeling time points, and appropriate experimental controls.

 

2. Time-Resolved Hydrogen-Deuterium Exchange

Expose purified proteins and their corresponding complexes to deuterated buffer at selected time points. Maintain controlled labeling conditions to enable comparison of backbone amide hydrogen exchange between protein states.

 

3. Exchange Quenching and Online Digestion

Quench the exchange reaction under low-temperature, acidic conditions, followed by online enzymatic digestion to generate peptides while minimizing deuterium back-exchange.

 

4. High-Resolution LC-MS Analysis

Separate peptides using low-temperature reversed-phase chromatography and analyze them on a high-resolution Q-TOF mass spectrometry platform. DDA-MS/MS supports peptide identification, while MS1 mass shifts in deuterated samples are used to quantify deuterium incorporation.

 

5. Differential HDX Analysis and Structural Mapping

Calculate peptide-level deuterium uptake and compare exchange profiles across experimental conditions. Evaluate reproducible differences, generate exchange kinetics curves, and map affected regions onto suitable experimental or predicted protein structures.

Schaefer A, Naser D, et al. J Biol Chem. 2022

Figure 1. Overview of a HDX-MS Workflow

Service Advantages

1. Project Feasibility Assessment

We evaluate protein quality, binding evidence, and buffer compatibility before analysis to identify potential experimental challenges and help establish a suitable project strategy.

 

2. Customized Experimental Design

Our team tailors comparison groups, labeling time points, and experimental conditions to your protein system and research objectives, supporting meaningful and reproducible HDX-MS comparisons.

 

3. Comprehensive Data Reporting

We provide raw MS data, peptide coverage, differential HDX results, and structural visualizations when applicable, together with clear interpretation to support subsequent research decisions.

 

4. One-Time Charge

Our pricing is transparent, with no hidden fees or additional costs.

 

Applications

1. Therapeutic Antibody Discovery

Antibody-antigen interactions are central to therapeutic antibody development. HDX-MS can identify antigen regions affected by antibody binding, supporting epitope region mapping, antibody candidate comparison, and investigation of molecular recognition mechanisms.

 

2. Drug Target and Regulatory Protein Research

Interactions between drug targets and regulatory proteins can influence molecular activity and signaling mechanisms. Comparative HDX-MS provides structural evidence of target-regulator association, helping researchers investigate binding-dependent changes and prioritize regions for mechanistic validation.

 

3. Protein Engineering and Biotherapeutic Design

Protein engineering frequently involves modifying binding properties or structural stability. HDX-MS comparisons of purified wild-type and engineered variants can reveal differences in regional protection and conformational responses, providing information for candidate evaluation and subsequent protein optimization.

 

4. Signaling Protein Complex Research

Signaling pathways often involve interactions among regulatory proteins, adaptor proteins, and scaffold proteins. HDX-MS analysis of purified or reconstituted complexes can reveal structural changes associated with these interactions, supporting research into complex assembly and molecular signaling mechanisms.

 

Sample Submission Requirements

Purified proteins with suitable structural stability and established binding conditions are recommended for HDX-MS analysis.

Parameter	Recommended Requirements
Sample Type	Purified proteins and their interacting protein partners
Protein Purity	≥90%
Protein Concentration	Approximately 1 mg/mL
Recommended Protein Quantity	Approximately 100 µg of protein as a starting reference; final quantities for each protein and experimental condition are confirmed during project evaluation
Binding Information	Previous binding evidence, such as SPR results, and established in vitro binding conditions are recommended
Sample Form	Purified proteins in powder or solution form
Storage and Shipping	Snap-freeze solutions in liquid nitrogen and ship on dry ice
Buffer Requirements	Buffer composition must preserve protein stability and binding while remaining compatible with HDX-MS

Please provide protein sequences, molecular weights, purification details, buffer composition, and available binding data before sample submission. Protein systems with substantial aggregation, instability, excessive complexity, or limited material require additional feasibility assessment.

 

Case Study

HDX-MS was combined with X-ray crystallography and cryo-EM to characterize the interaction between TMEM106B and the SARS-CoV-2 spike protein. The study identified engagement of the TMEM106B luminal domain with the spike receptor-binding motif and showed that the E484D substitution enhanced binding, demonstrating the value of HDX-MS for defining protein-protein interaction interfaces and supporting structural interpretation.

Baaggen J, Jacquemyn M, et al. Cell. 2023.

Figure 2. HDX-MS Mapping of the TMEM106B–SARS-CoV-2 Spike Interaction

Deliverables

1. Raw MS Data

Original LC-MS data files.

2. Protein Sequence Coverage

Identified peptides and sequence coverage information.

3. Differential HDX Results

Deuterium uptake measurements and comparative statistics across labeling time points.

4. Binding-Associated Region Analysis

Candidate interaction regions and differential protection profiles.

5. Data Visualization

Exchange kinetics curves, PCA results, and 3D structural mapping when applicable.

6. Final Report

PDF report summarizing experimental results and structural interpretation.

 

FAQ

Q1. Can HDX-MS determine the binding affinity between two proteins?

No. HDX-MS characterizes structural changes associated with protein binding rather than directly measuring binding affinity or dissociation constants. SPR or BLI can provide quantitative affinity and kinetic measurements.

 

Q2. What happens if the suspected binding region has insufficient peptide coverage?

Regions with insufficient peptide coverage cannot be reliably evaluated by HDX-MS. Depending on the protein sequence and sample properties, digestion conditions or peptide identification strategies may be assessed to improve coverage. An uncovered region cannot be excluded from potential involvement in binding.

 

Q3. Can HDX-MS characterize weak or transient protein-protein interactions?

Some weak or transient interactions can be characterized when sufficient complex occupancy is maintained during labeling. Feasibility depends on binding affinity, protein concentration, complex stability, and experimental conditions. Previous binding measurements can help determine whether HDX-MS is suitable.

 

Start Your Project with MtoZ Biolabs

Investigate the structural basis of your protein interactions with MtoZ Biolabs. Share your protein pair, available binding evidence, and research objectives with our team to evaluate HDX-MS feasibility and develop a suitable comparative analysis strategy.